Fibrocell to Present at 21st Annual BIO CEO & Investor Conference
EXTON, PA — Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, announced that John Maslowski, President and Chief Executive …
Read More